Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
doi: 10.1007/s00018-019-03253-8 73 ZhangXCuiYDongLSunMZhangY
Glucose-lowering drugs that stimulate insulin secretion Glucose-lowering drugs that stimulate insulin secretion Sulfonylureas: Sulfonylureas are classified as insulin secretagogues and their primary mechanism of action is to stimulate pancreatic beta cells to secrete insulin, effectively lowering blood glucose levels
G., Martin, E
The GLP-1 drugs are the latest class to show a benefit in patients, this time with OSA, but like other tools have nontrivial side effects, cost concerns, and patient persistence issues that balance out the headline benefits. The size of the underlying patient populations, which are expected to surpass 1.3 billion globally by 2050, as well as the under penetration of CPAP treatment, which Andrew ballparks at 15% or less in many markets, reinforces the analysts argument
Patients receive unclear instructions about measuring doses, use the wrong syringe type, or misunderstand the differences between formulation strengths
L.HnninenT.et al (1999)
